IOVA vs. MATW
Compare and contrast key facts about Iovance Biotherapeutics, Inc. (IOVA) and Matthews International Corporation (MATW).
Performance
IOVA vs. MATW - Performance Comparison
Loading graphics...
IOVA vs. MATW - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IOVA Iovance Biotherapeutics, Inc. | 28.57% | -63.11% | -8.98% | 27.23% | -66.53% | -58.86% | 67.63% | 212.77% | 10.62% | 15.11% |
MATW Matthews International Corporation | -0.21% | -1.50% | -21.25% | 23.36% | -14.50% | 27.72% | -20.49% | -3.95% | -21.88% | -30.53% |
Fundamentals
IOVA:
$1.43B
MATW:
$812.40M
IOVA:
-$1.06
MATW:
$0.72
IOVA:
4.91
MATW:
0.58
IOVA:
2.04
MATW:
1.50
IOVA:
$263.50M
MATW:
$1.38B
IOVA:
$256.22M
MATW:
$469.95M
IOVA:
-$357.11M
MATW:
$227.64M
Returns By Period
In the year-to-date period, IOVA achieves a 28.57% return, which is significantly higher than MATW's -0.21% return. Over the past 10 years, IOVA has outperformed MATW with an annualized return of -3.87%, while MATW has yielded a comparatively lower -4.35% annualized return.
IOVA
- 1D
- 5.72%
- 1M
- -9.07%
- YTD
- 28.57%
- 6M
- 61.75%
- 1Y
- 5.41%
- 3Y*
- -16.87%
- 5Y*
- -35.81%
- 10Y*
- -3.87%
MATW
- 1D
- 2.58%
- 1M
- -2.31%
- YTD
- -0.21%
- 6M
- 8.48%
- 1Y
- 21.18%
- 3Y*
- -7.12%
- 5Y*
- -5.83%
- 10Y*
- -4.35%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IOVA vs. MATW — Risk / Return Rank
IOVA
MATW
IOVA vs. MATW - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Iovance Biotherapeutics, Inc. (IOVA) and Matthews International Corporation (MATW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IOVA | MATW | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.05 | 0.56 | -0.51 |
Sortino ratioReturn per unit of downside risk | 0.95 | 1.06 | -0.11 |
Omega ratioGain probability vs. loss probability | 1.13 | 1.12 | 0.00 |
Calmar ratioReturn relative to maximum drawdown | -0.03 | 1.22 | -1.24 |
Martin ratioReturn relative to average drawdown | -0.04 | 2.66 | -2.70 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| IOVA | MATW | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.05 | 0.56 | -0.51 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.40 | -0.16 | -0.23 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.05 | -0.12 | +0.07 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.14 | 0.22 | -0.36 |
Correlation
The correlation between IOVA and MATW is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
IOVA vs. MATW - Dividend Comparison
IOVA has not paid dividends to shareholders, while MATW's dividend yield for the trailing twelve months is around 3.91%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IOVA Iovance Biotherapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
MATW Matthews International Corporation | 3.91% | 3.85% | 4.37% | 2.54% | 2.92% | 2.36% | 2.87% | 2.12% | 1.90% | 1.33% | 0.81% | 1.01% |
Drawdowns
IOVA vs. MATW - Drawdown Comparison
The maximum IOVA drawdown since its inception was -99.37%, which is greater than MATW's maximum drawdown of -75.27%. Use the drawdown chart below to compare losses from any high point for IOVA and MATW.
Loading graphics...
Drawdown Indicators
| IOVA | MATW | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.37% | -75.27% | -24.10% |
Max Drawdown (1Y)Largest decline over 1 year | -54.41% | -16.18% | -38.23% |
Max Drawdown (5Y)Largest decline over 5 years | -94.98% | -58.68% | -36.30% |
Max Drawdown (10Y)Largest decline over 10 years | -96.84% | -75.27% | -21.57% |
Current DrawdownCurrent decline from peak | -97.79% | -56.84% | -40.95% |
Average DrawdownAverage peak-to-trough decline | -84.00% | -24.53% | -59.47% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 37.72% | 7.38% | +30.34% |
Volatility
IOVA vs. MATW - Volatility Comparison
Iovance Biotherapeutics, Inc. (IOVA) has a higher volatility of 30.93% compared to Matthews International Corporation (MATW) at 7.71%. This indicates that IOVA's price experiences larger fluctuations and is considered to be riskier than MATW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| IOVA | MATW | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 30.93% | 7.71% | +23.22% |
Volatility (6M)Calculated over the trailing 6-month period | 65.62% | 22.59% | +43.03% |
Volatility (1Y)Calculated over the trailing 1-year period | 112.34% | 37.79% | +74.55% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 90.77% | 36.24% | +54.53% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 81.92% | 36.86% | +45.06% |
Financials
IOVA vs. MATW - Financials Comparison
This section allows you to compare key financial metrics between Iovance Biotherapeutics, Inc. and Matthews International Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities